Mira Ovum Wand Menopause and Fertility Predictor
Mira has launched the Mira Ovum Wand as an over-the-counter tool to detect follicle-stimulating hormone (FSH) in urine. The product has been listed by the US Food and Drug Administration and will be available to US customers in October 2022. The test helps monitor FSH levels to predict approaching menopause, assess fertility, and find possible causes of reproductive issues for women over 35 years of age. It can also help track the effectiveness of hormone replacement therapy to potentially make it more targeted and personalized.
The Mira Ovum Wand is compatible with the Mira Analyzer testing device, which uses machine learning to track changing hormone patterns over time. The analyzer can be connected to the Mira App to display numerical data along with personalized insights on the user's reproductive health.